SCHEMBL9194286

SCHEMBL9194286

CCc1cccc(CC)c1NC(=O)NC(c1ccccc1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.57
▸ ANPEP P15144 1/20 0.55
▸ NPSR1 Q6W5P4 2/20 0.51
▸ CACNA1C Q13936 2/20 0.49
▸ SCN5A Q14524 2/20 0.49
▸ CNR1 P21554 2/20 0.48
▸ CA12 O43570 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ TSHR P16473 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9195227 0.81 HTT (0.54) HTTANPEPALDH1A1SMN1; SMN2
SCHEMBL9504011 0.80 HTT (0.52) HTTANPEPCACNA1CSCN5A
SCHEMBL9678877 0.79 TDP1 (0.58) HTTALDH1A1TSHRCYP2C19ALOX15
SCHEMBL9504118 0.78 LMNA (0.58) KMT2ALMNA
SCHEMBL24575947 0.75 HPGDS (0.57) HTTNPSR1CACNA1CCNR1CA12
SCHEMBL13480537 0.75 NPSR1 (0.58) NPSR1CNR1CA12CA1CA2
SCHEMBL15897742 0.73 CACNA1C (0.61) HTTANPEPNPSR1CACNA1CSCN5A
SCHEMBL8364624 0.72 NPSR1 (0.54) NPSR1CNR1CA12CA1CA2
SCHEMBL9723518 0.72 LMNA (0.54) KMT2ALMNA
SCHEMBL18415577 0.72 HTT (0.58) HTTANPEPNPSR1CACNA1CSCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0335374-B1 N-[[(2,6-disubstituted)phenyl]-N'-diarylalkyl] ureas as antihyperlipidemic and antiatherosclerotic agents WARNER-LAMBERT COMPANY (US) 1993-06-30 — — EP claimed
US-5116848-A N-(((2,6-DISUBSTITUTED)PHENYL)-N-DIARYLALKYL)UREAS AS ANTIHYPERLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS WARNER-LAMBERT COMPANY (US) 1992-05-26 — — US claimed
EP-0500348-B1 Disubstituted ureas and thioureas PHARMACIA SPA (IT) 1995-05-17 — — EP disclosed
EP-0335374-B1 N-[[(2,6-disubstituted)phenyl]-N'-diarylalkyl] ureas as antihyperlipidemic and antiatherosclerotic agents WARNER-LAMBERT COMPANY (US) 1993-06-30 — — EP disclosed
US-5116848-A N-(((2,6-DISUBSTITUTED)PHENYL)-N-DIARYLALKYL)UREAS AS ANTIHYPERLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS WARNER-LAMBERT COMPANY (US) 1992-05-26 — — US disclosed
EP-0335374-A2 N-[[(2,6-disubstituted)phenyl]-N'-diarylalkyl] ureas as antihyperlipidemic and antiatherosclerotic agents WARNER-LAMBERT COMPANY (US) 1989-10-04 — — EP disclosed
Send feedback